J. Goldman & Co’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-96,251
Closed -$706K 563
2024
Q2
$706K Sell
96,251
-367,639
-79% -$3.21M 0.02% 334
2024
Q1
$4.64M Buy
463,890
+157,690
+51% +$1.38M 0.15% 152
2023
Q4
$2.15M Buy
+306,200
New +$2.04M 0.09% 182
2023
Q3
Sell
-709,925
Closed -$4.48M 443
2023
Q2
$3.93M Buy
+709,925
New +$3.89M 0.14% 161
2023
Q1
Sell
-336,285
Closed -$2.23M 441
2022
Q4
$2.35M Buy
+336,285
New +$3.46M 0.12% 167
2022
Q3
Sell
-58,500
Closed -$675K 449
2022
Q2
$605K Buy
+58,500
New +$869K 0.03% 275
2022
Q1
Sell
-75,000
Closed -$1.64M 415
2021
Q4
$1.92M Buy
+75,000
New +$2.07M 0.11% 205

Other funds holding MSOS

J. Goldman & Co's MSOS Position: Q3 2024 in Review

J. Goldman & Co sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q3 2024, closing a stake of 96,251 shares — an estimated $706K sold.

J. Goldman & Co first reported a position in MSOS in Q4 2021 and held it in 7 quarters. The position peaked at $4.64M in Q1 2024. 170 funds tracked by Wall St. Rank hold MSOS as of Q3 2024.

  • J. Goldman & Co reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q3 2024 after selling out during the quarter.
  • J. Goldman & Co sold 96,251 AdvisorShares Pure US Cannabis ETF shares in Q3 2024, an estimated $706K.
  • J. Goldman & Co first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2021 and held it in 7 quarters.
  • J. Goldman & Co's AdvisorShares Pure US Cannabis ETF position peaked at $4.64M in Q1 2024.
  • 170 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2024.

Based on J. Goldman & Co's 13F filing for Q3 2024, filed 14 Nov 2024.